
Alzheon
Developer of a small molecule-based drug discovery platform designed to treat Alzheimer's disease and other neurodegenerative disorders. The company's platform specializes in the development of oral i...
Valuation
$0
Share Price
N/A
Total Raised
$212.2M
Last Round
N/A